Reuters logo
BRIEF-Ironwood announces new drug application for DUZALLO has been accepted for FDA review
January 4, 2017 / 1:06 PM / a year ago

BRIEF-Ironwood announces new drug application for DUZALLO has been accepted for FDA review

Jan 4 (Reuters) - Ironwood Pharmaceuticals Inc :

* Ironwood announces new drug application for duzallo(tm) (fixed-dose combination of lesinurad and allopurinol) has been accepted for fda review

* Ironwood pharmaceuticals inc- fda prescription drug user fee act (pdufa) target action date is expected to occur in second half of 2017

* Ironwood pharmaceuticals inc- if approved, duzallo is expected to be commercially available in late 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below